Taubman Institute to appoint six new scholars in 2014
Six new Taubman Scholars -- clinician-scientists selected from among the University of Michigan Medical School faculty -- will be appointed in 2014 by the A. Alfred Taubman Medical Research Institute.
Taubman Scholar grants provide $150,000 per year for three years for these select physician researchers, who combine an active clinical practice with basic laboratory science seeking new treatments and cures for the diseases they treat. The grants are intended to fund the "high risk, high reward" research that often is overlooked by traditional sources of financial support. In the five years since the institute's inception, the research of Taubman Scholars and Taubman Emerging Scholars has led to nearly three dozen human clinical trials of new drugs and therapies for diseases ranging from cancer to muscular dystrophy to ALS.
Prospective scholars must hold an M.D. degree and have until Dec. 1 to complete the application form, which will be vetted by the institute's scientific advisory board, a panel comprised of eminent medical scientsists from outside the university. Click here for complete details and the application form.
Stem cell symposium set for Sept. 19 in Ann Arbor
Dr. Eva Feldman will be among the speakers at the one-day event, which focuses on cutting-edge developments in stem-cell biology, epigenetics and regneratrive medicine.
Click here for details and registration.
New U-M President visits Taubman Institute
The Institute hosted a fellow clinician-scientist when the University of Michigan’s new president paid a visit to the A. Alfred Taubman Biomedical Science Research Building.
People who care
Institute welcomes new gift officer
Maria Muller has been appointed to work with connect donors with funding opportunities at the Taubman Institute.
Click here to read more.
news & events
Institute symposium set for Oct. 10
The A. Alfred Taubman Medical Research Institute will award the 2014 $100,000 Taubman Prize for Excellence in Translational Medical Science at its 7th annual symposium at 10 a.m. on Oct. 10.
Dr. Carl June, a physician-scientist who developed a personalized immunotherapy for leukemia using patients’ own T cells, will receive the honor and deliver the symposium's keynote address.
Click here for symposium details.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.